Frédéric Mascha, the founder
Frédéric MASCHA holds an MBA from Harvard Business School (Boston, USA) and graduated from the Institut Supérieur de Gestion in Paris (France).
Former Principal Partner at McKinsey & Co, Frédéric MASCHA has developed numerous strategies on behalf of large global pharmaceutical groups. In particular, it has made it possible to optimize the launch of several drugs dedicated to the treatment of disorders of the central nervous system, diabetes, cardiovascular diseases and gastrointestinal pathologies.